Browsing Tag
Orexin Receptor Antagonist
1 post
Indivior initiates Phase 2 study for INDV-2000, targeting opioid use disorder with non-opioid treatment
Indivior PLC (LSE/Nasdaq: INDV) has announced the commencement of a Phase 2 clinical trial involving INDV-2000, a non-opioid…